"Z\u00E1v\u011Bre\u010Dn\u00E1 zpr\u00E1va Fakultn\u00ED nemocnice Hradec Kr\u00E1lov\u00E9 ke klinick\u00E9mu hodnocen\u00ED protokol \u010D. P04103"@cs . . . "Final report of University Hospital Hradec Kralove to the clinical trial protocol no. P04103"@en . "RIV/00179906:_____/13:10210774" . "Realization of a part of clinical study called A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs Simvastatin Monotherapy in High-Risk Subjects Presenting With Acute Coronary Syndrome (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial - IMPROVE IT)"@en . . . . "1" . "Z\u00E1v\u011Bre\u010Dn\u00E1 zpr\u00E1va Fakultn\u00ED nemocnice Hradec Kr\u00E1lov\u00E9 ke klinick\u00E9mu hodnocen\u00ED protokol \u010D. P04103" . . . "Merck Sharp & Dohme" . . "Z\u00E1v\u011Bre\u010Dn\u00E1 zpr\u00E1va Fakultn\u00ED nemocnice Hradec Kr\u00E1lov\u00E9 ke klinick\u00E9mu hodnocen\u00ED protokol \u010D. P04103"@cs . . "RIV/00179906:_____/13:10210774!RIV14-MZ0-00179906" . . "Acute Coronary Syndrome; simvastatin; vytorin"@en . "1"^^ . "N" . "Final report of University Hospital Hradec Kralove to the clinical trial protocol no. P04103"@en . "2"^^ . "Proveden\u00ED \u010D\u00E1sti klinick\u00E9ho hodnocen\u00ED s n\u00E1zvem Multicentrick\u00E1, dvojit\u011B zaslepen\u00E1, randomizovan\u00E1 studie s c\u00EDlem stanovit klinick\u00FD p\u0159\u00EDnos a bezpe\u010Dnost Vytorinu (tableta obsahuj\u00EDc\u00ED ezetimib/simvastatin) oproti terapii samotn\u00FDm simvastatinem u jedinc\u016F s vysok\u00FDm rizikem p\u0159ich\u00E1zej\u00EDc\u00EDch k vy\u0161et\u0159en\u00ED s akutn\u00EDm koron\u00E1rn\u00EDm syndromem (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial)" . "1"^^ . "[10785FF64EE2]" . . "Z\u00E1v\u011Bre\u010Dn\u00E1 zpr\u00E1va Fakultn\u00ED nemocnice Hradec Kr\u00E1lov\u00E9 ke klinick\u00E9mu hodnocen\u00ED protokol \u010D. P04103" . . "Sola\u0159, Miroslav" . "118429" . "Proveden\u00ED \u010D\u00E1sti klinick\u00E9ho hodnocen\u00ED s n\u00E1zvem Multicentrick\u00E1, dvojit\u011B zaslepen\u00E1, randomizovan\u00E1 studie s c\u00EDlem stanovit klinick\u00FD p\u0159\u00EDnos a bezpe\u010Dnost Vytorinu (tableta obsahuj\u00EDc\u00ED ezetimib/simvastatin) oproti terapii samotn\u00FDm simvastatinem u jedinc\u016F s vysok\u00FDm rizikem p\u0159ich\u00E1zej\u00EDc\u00EDch k vy\u0161et\u0159en\u00ED s akutn\u00EDm koron\u00E1rn\u00EDm syndromem (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial)"@cs . . . .